Koers Titan Medical Inc. Toronto S.E.
Aandelen
CA88830X1087
Geavanceerde medische apparatuur & technologie
Omzet 2022 | - | Omzet 2023 | 17,63 24,1 16,28 | Marktkapitalisatie | 6,87 mln. 9,39 mln. 6,34 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -42 mln. -57,41 mln. -38,77 mln. | Nettowinst (verlies) 2023 | 6 mln. 8,2 mln. 5,54 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 1,58 mln. 2,16 mln. 1,46 mln. | Nettoliquiditeiten 2023 | 6,27 mln. 8,57 mln. 5,78 mln. | EV/omzet 2023 | 34.203 x |
K/w-verhouding 2022 |
-1,74
x | K/w-verhouding 2023 |
1,01
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 99,58% |
Recentste transcriptie over Titan Medical Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Cataford
CEO | Chief Executive Officer | 60 | 30-09-20 |
Chien Huang
DFI | Director of Finance/CFO | - | - |
Cary Vance
BRD | Director/Board Member | 58 | 30-09-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Paul Cataford
CEO | Chief Executive Officer | 60 | 30-09-20 |
Director/Board Member | 67 | 30-09-20 | |
Cary Vance
BRD | Director/Board Member | 58 | 30-09-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,16% | 225 mld. | |
+15,76% | 197 mld. | |
+19,03% | 143 mld. | |
+30,31% | 111 mld. | |
+2,78% | 64,72 mld. | |
+19,30% | 54,44 mld. | |
+5,12% | 51,06 mld. | |
+10,72% | 45,03 mld. | |
+4,51% | 37,4 mld. |